study
Paolo Tarantino: Individualizing T-DXd Treatment Duration in HER2-Positive Breast Cancer
OncoDaily · 7h ago
Untick a publication to hide it; your selections are stored in this browser. Journals, preprint servers, consumer brands and other high-volume feeds are off by default.
Medicine & Biotech · covered by 8 outlets this week · tracked since 2026-10-29
Press: 2 specialist 6 independent outlet-days